These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34955446)

  • 1. Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial.
    Pearce J; Swinson D; Cairns D; Nair S; Baxter M; Petty R; Seymour M; Hall P; Velikova G;
    J Geriatr Oncol; 2022 Apr; 13(3):287-293. PubMed ID: 34955446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.
    Hall PS; Swinson D; Cairns DA; Waters JS; Petty R; Allmark C; Ruddock S; Falk S; Wadsley J; Roy R; Tillett T; Nicoll J; Cummins S; Mano J; Grumett S; Stokes Z; Kamposioras KV; Chatterjee A; Garcia A; Waddell T; Guptal K; Maisey N; Khan M; Dent J; Lord S; Crossley A; Katona E; Marshall H; Grabsch HI; Velikova G; Ow PL; Handforth C; Howard H; Seymour MT;
    JAMA Oncol; 2021 Jun; 7(6):869-877. PubMed ID: 33983395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study.
    Anic K; Varchola J; Schmidt MW; Schwab R; Linz VC; Schmidt M; Hardt R; Hartmann EK; Ruckes C; Hasenburg A; Battista MJ
    Arch Gynecol Obstet; 2023 Jun; 307(6):1929-1940. PubMed ID: 36434440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
    Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
    J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
    Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.
    Kim VS; Yang H; Timilshina N; Breunis H; Emmenegger U; Gregg R; Hansen AR; Tomlinson G; Alibhai SMH
    J Geriatr Oncol; 2023 Mar; 14(2):101417. PubMed ID: 36682218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frailty in Non-geriatric Patients With Head and Neck cancer.
    Bakas AT; Polinder-Bos HA; Streng F; Mattace-Raso FUS; Ziere G; de Jong RJB; Sewnaik A
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1215-1224. PubMed ID: 37264978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
    Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A
    BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study.
    Anic K; Flohr F; Schmidt MW; Krajnak S; Schwab R; Schmidt M; Westphalen C; Eichelsbacher C; Ruckes C; Brenner W; Hasenburg A; Battista MJ
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1551-1560. PubMed ID: 35579719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
    Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
    Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative frailty assessment with the Robinson Frailty Score, Edmonton Frail Scale, and G8 and adverse postoperative outcomes in older surgical patients with cancer.
    Nishijima TF; Esaki T; Morita M; Toh Y
    Eur J Surg Oncol; 2021 Apr; 47(4):896-901. PubMed ID: 33036830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for frailty among older patients with cancer that qualify for abdominal surgery.
    Kenig J; Zychiewicz B; Olszewska U; Richter P
    J Geriatr Oncol; 2015 Jan; 6(1):52-9. PubMed ID: 25277874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two frailty screening tools in older patients with colorectal cancer.
    Zhao H; Lu X; Zheng S; Wei D; Zhao L; Wang Y; de Bock GH; Lu W
    BMC Geriatr; 2023 May; 23(1):295. PubMed ID: 37189055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study.
    Anic K; Altehoefer C; Krajnak S; Schmidt MW; Schwab R; Linz VC; Schmidt M; Westphalen C; Hartmann EK; Hasenburg A; Battista MJ
    J Cancer Res Clin Oncol; 2023 Feb; 149(2):851-863. PubMed ID: 35212815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
    AlSendi M; Flynn CR; Khan MR; Selvadurai P; Crown J; McDermott RS; Walshe JM; Fennelly DW; Hanrahan EO; Doherty M; Higgins MJ
    Ir J Med Sci; 2024 Feb; 193(1):45-50. PubMed ID: 37450258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G8 frailty screening tool and the decision-making process in older breast cancer patients.
    Scheepers ERM; van der Molen LF; van den Bos F; Burgmans JP; van Huis-Tanja LH; Hamaker ME
    Eur J Cancer Care (Engl); 2021 Jan; 30(1):e13357. PubMed ID: 33159382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
    Herbst RS; Arkenau HT; Santana-Davila R; Calvo E; Paz-Ares L; Cassier PA; Bendell J; Penel N; Krebs MG; Martin-Liberal J; Isambert N; Soriano A; Wermke M; Cultrera J; Gao L; Widau RC; Mi G; Jin J; Ferry D; Fuchs CS; Petrylak DP; Chau I
    Lancet Oncol; 2019 Aug; 20(8):1109-1123. PubMed ID: 31301962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.